Cathryn Brock

1.7k total citations
17 papers, 821 citations indexed

About

Cathryn Brock is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Cathryn Brock has authored 17 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Cathryn Brock's work include Medical Imaging Techniques and Applications (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Glioma Diagnosis and Treatment (3 papers). Cathryn Brock is often cited by papers focused on Medical Imaging Techniques and Applications (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Glioma Diagnosis and Treatment (3 papers). Cathryn Brock collaborates with scholars based in United Kingdom, United States and Switzerland. Cathryn Brock's co-authors include Éric Raymond, Suzanne F. Jones, Howard A. Burris, Anne O’Donnell, Daniel Rea, Heidi A. Lane, N. Shand, Ian Judson, John M. Kovarik and Sandrine Faivre and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Cathryn Brock

16 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathryn Brock United Kingdom	10	358	291	262	171	158	17	821
Michelangelo Russillo Italy	15	420 1.2×	391 1.3×	585 2.2×	161 0.9×	236 1.5×	41	1.1k
Patrick Maier Germany	16	417 1.2×	140 0.5×	263 1.0×	139 0.8×	96 0.6×	31	889
Niamh Coleman United States	14	204 0.6×	256 0.9×	281 1.1×	110 0.6×	90 0.6×	41	662
Robert J. Mairs United Kingdom	21	334 0.9×	280 1.0×	238 0.9×	367 2.1×	79 0.5×	43	1.1k
K. Papadopoulos United States	16	598 1.7×	215 0.7×	540 2.1×	121 0.7×	90 0.6×	56	1.1k
Shikai Wu China	18	159 0.4×	284 1.0×	461 1.8×	85 0.5×	90 0.6×	73	796
Eugenio Villa Italy	14	215 0.6×	396 1.4×	676 2.6×	104 0.6×	106 0.7×	20	973
Olga Martínez‐Sáez Spain	11	293 0.8×	343 1.2×	458 1.7×	95 0.6×	81 0.5×	60	832
Hao‐Wen Sim Australia	17	364 1.0×	327 1.1×	326 1.2×	48 0.3×	162 1.0×	73	931
Graham H.P. Richmond United Kingdom	5	492 1.4×	321 1.1×	473 1.8×	61 0.4×	65 0.4×	6	947

Countries citing papers authored by Cathryn Brock

Since Specialization

Citations

This map shows the geographic impact of Cathryn Brock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathryn Brock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathryn Brock more than expected).

Fields of papers citing papers by Cathryn Brock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathryn Brock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathryn Brock. The network helps show where Cathryn Brock may publish in the future.

Co-authorship network of co-authors of Cathryn Brock

This figure shows the co-authorship network connecting the top 25 collaborators of Cathryn Brock. A scholar is included among the top collaborators of Cathryn Brock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathryn Brock. Cathryn Brock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nikolaou, Christos, Heather M. Shaw, Conal M. Perrett, et al.. (2022). HIV-related Merkel cell carcinoma: A report of three cases from the UK. International Journal of STD & AIDS. 33(12). 1084–1086. 1 indexed citations

Nogueira, Edson, et al.. (2021). Pituitary enlargement following ipilimumab without long term endocrine dysfunction. Current Problems in Cancer. 45(6). 100710–100710.

Pinato, David J., Sarah Howlett, Diego Ottaviani, et al.. (2019). Antibiotic treatment prior to immune checkpoint inhibitor therapy as a tumor-agnostic predictive correlate of response in routine clinical practice.. Journal of Clinical Oncology. 37(8_suppl). 147–147. 12 indexed citations

Black, James R., Robert Goldin, Matthew Foxton, et al.. (2019). PD-L1 Expressing Granulomatous Reaction As An On-Target Mechanism of Steroid-Refractory Immune Hepatotoxicity. Immunotherapy. 11(7). 585–590. 7 indexed citations

Kenny, Laura, Giampaolo Tomasi, Federico Turkheimer, et al.. (2014). Preliminary clinical assessment of the relationship between tumor alphavbeta3 integrin and perfusion in patients studied with [18F]fluciclatide kinetics and [15O]H2O PET. EJNMMI Research. 4(1). 30–30. 3 indexed citations

Shamash, Jonathan, Justin Stebbing, Guru Sonpavde, et al.. (2010). A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate‐resistant prostate cancer. Cancer. 116(15). 3595–3602. 19 indexed citations

O’Donnell, Anne, Sandrine Faivre, Howard A. Burris, et al.. (2008). Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 26(10). 1588–1595. 371 indexed citations

Rosso, Lula, Cathryn Brock, James M. Gallo, et al.. (2008). A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients. Cancer Research. 69(1). 120–127. 125 indexed citations

Powles, Tom, Iain Murray, Cathryn Brock, R.T.D. Oliver, & Norbert Avril. (2007). Molecular Positron Emission Tomography and PET/CT Imaging in Urological Malignancies. European Urology. 51(6). 1511–1521. 110 indexed citations

10.

Shousha, Sami, et al.. (2007). Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast. Journal of Cutaneous Pathology. 34(12). 934–938. 6 indexed citations

11.

Mulholland, Paul, Christina Thirlwell, Cathryn Brock, & E.S. Newlands. (2005). Emerging targeted treatments for malignant glioma. Expert Opinion on Emerging Drugs. 10(4). 845–854. 4 indexed citations

12.

Stebbing, Justin, Simon Portsmouth, Mark Nelson, et al.. (2003). The efficacy of ritonavir in the prevention of AIDS‐related Kaposi's sarcoma. International Journal of Cancer. 108(4). 631–633. 22 indexed citations

13.

Dark, G., Christina Thirlwell, & Cathryn Brock. (2003). Emergencies in oncology. Clinical Medicine. 3(4). 306–310. 3 indexed citations

14.

Saleem, Azeem, Frank Brady, Eric O. Aboagye, et al.. (2003). Metabolic activation of temozolomide measured in vivo using positron emission tomography.. PubMed. 63(10). 2409–15. 64 indexed citations

15.

Luthra, Sajinder K., et al.. (2002). Antitumor Imidazotetrazines. 40. Radiosyntheses of [4-¹¹C-Carbonyl]- and [3-N-¹¹C-Methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (Temozolomide) for Positron Emission Tomography (PET) Studies. Journal of Medicinal Chemistry. 45(25). 5448–5457. 21 indexed citations

16.

Young, Helen, Cathryn Brock, Paula Wells, & Pat Price. (1999). Monitoring Response to Treatment in the Development of Anti-Cancer Drugs Using Positron Emission Tomography (PET). Drug Information Journal. 33(1). 237–244. 11 indexed citations

17.

Meikle, Steven R., Julian C. Matthews, Cathryn Brock, et al.. (1998). Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: A feasibility study. Cancer Chemotherapy and Pharmacology. 42(3). 183–193. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact